OKUR
OnKure Therapeutics, Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$170.06M
P/E Ratio
—
EPS
$-4.32
Beta
—
52W High
$5.38
52W Low
$1.91
50-Day MA
$4.24
200-Day MA
$3.18
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About OnKure Therapeutics, Inc.
OnKure, Inc. engages in the discovery and development of oncology-precision medicines for the treatment of cancer. The company is headquartered in Boulder, Colorado.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-61.13M |
| Operating Margin | 0.00% |
| Return on Equity | -42.70% |
| Return on Assets | -25.80% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $4.56 |
| Price-to-Book | 0.92 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 0.03 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $40.40M |
| Float | $19.64M |
| % Insiders | 10.47% |
| % Institutions | 74.91% |
Historical Volatility
HV 10-Day
117.97%
HV 20-Day
102.51%
HV 30-Day
88.84%
HV 60-Day
88.65%
HV Rank
92.1%
Volatility is currently expanding
Analyst Ratings
Consensus ($20.20 target)
6
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026